Has Craig Nakamura received payments from drug or device companies?

Yes. Drug and device makers reported $263,362 in general payments to Craig Nakamura across 915 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Craig Nakamura did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Craig Nakamura come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Craig Nakamura

Pediatric Pulmonology · Las Vegas, NVNPI 1295721918

Payments from drug & device makers

$263,362in general payments, 2019–2025

Across 915 payments — averaging $287.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biogen$134K
First Wave Biopharma, Inc.$56K
Chiesi USA, Inc.$22K
Sobi, Inc$15K
Gilead$11K
Boehringer Ingelheim$7K
plus $18K from 40 others

What the payments were for

Consulting fees$31,09715%
Speaking & faculty fees$144,13870%
Travel & lodging$15,2607%
Food & beverage$15,8988%
Education$8550%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biogen	159	$134,358
First Wave Biopharma, Inc.	1	$56,115
Chiesi USA, Inc.	76	$21,861
Sobi, Inc	27	$15,079
Gilead	55	$11,248
Boehringer Ingelheim	13	$6,684
Genentech USA, Inc.	21	$4,944
Sanofi	55	$1,316
Regeneron Healthcare Solutions, Inc.	52	$1,303
AstraZeneca	61	$1,098
GSK	68	$1,079
Hill-rom Company, Inc	1	$1,000
Advanced Respiratory, Inc	27	$942
Vertex	33	$818
AbbVie(2 entities)	36	$674
Philips North America LLC	45	$626
Baxter Healthcare	21	$508
Amgen	24	$435
Nestle Healthcare Nutrition Inc.	19	$373
Alcresta Therapeutics, Inc.	5	$359
Sanofi-aventis U.S. LLC	8	$356
Digestive Care, Inc.	3	$279
Aimmune Therapeutics, Inc.	9	$228
Electromed, Inc.	24	$225
Novartis	10	$169
Insmed, Inc.	8	$148
Jazz Pharmaceuticals Inc.	8	$140
Tactile Systems Technology Inc	5	$108
Harmony Biosciences LLC	1	$100
Kaleo, Inc.	4	$90
Avadel CNS Pharmaceuticals, LLC	4	$89
Mylan Specialty L.p.	5	$89
Pharming Healthcare, Inc.	4	$84
Vivus LLC	4	$70
Takeda Pharmaceuticals U.S.A., Inc.	2	$56
ARS Pharmaceuticals Operations, Inc.	3	$50
NS Pharma, Inc.	2	$45
Covis Pharma GmbH	2	$34
Merck	2	$29
Breas Medical, Inc.	2	$28
Sanofi Pasteur Inc.	1	$25
Dexcom, Inc.	1	$24
Resmed Corp	1	$22
Kyowa Kirin, Inc.	1	$22
Sun Pharmaceutical Industries Inc.	1	$20
Circassia Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric pulmonology providers in Nevadato place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Montelukast Sodium	12	$42

Paid to pharmacies, not to this prescriber.

Other pediatric pulmonology in Las Vegas

David ParksLas Vegas$2K
Evelyn Montalvo StantonLas Vegas$455
Sonia BudhechaReno$86K
Shipra SinghReno$345
Kelly TuvesonReno$262

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →